Tirzepatide/Pyridoxine(B6) 10/1 mg/mL

Generic For: Mounjaro

Tirzepatide/Pyridoxine(B6) 10/1 mg/mL is a compounded injection combining tirzepatide — the active ingredient in Mounjaro — with vitamin B6. Tirzepatide is a dual GIP/GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes and to support chronic weight management. Ships from a licensed U.S. pharmacy after review of your prescription by a licensed provider.

Select Quantity *

30-day supply · $125.00/mL

How It Works

  1. Select your medication
  2. Licensed providers review & prescribe
  3. Our licensed U.S. pharmacists fill your prescription
  4. Delivered to you as soon as the next day

Price: $250.00

HSA/FSA Eligible
Get Started

*Doctor visit fee & delivery cost not included in price. Refills at provider discretion.

Pharmacist Support Fast Shipping Licensed U.S. Pharmacy

Buy Tirzepatide/Pyridoxine(B6) 10/1 mg/mL Injection Online

A GIP/GLP-1 receptor agonist injection used for type 2 diabetes and chronic weight management

Tirzepatide/Pyridoxine(B6) 10/1 mg/mL Quick Facts

Drug classGIP/GLP-1 receptor agonist
TreatsType 2 diabetes, chronic weight management
FormInjection
Typical dosingINJECT ONCE A WEEK. FOLLOW DIRECTIONS ON ENCLOSED SHEET. Dispense alcohol prep pads and 1 mL syringes QS.
Prescription requiredYes — prescription only

What Is Tirzepatide/Pyridoxine(B6) 10/1 mg/mL?

Tirzepatide/Pyridoxine(B6) 10/1 mg/mL is a compounded injectable medication that pairs tirzepatide with pyridoxine (vitamin B6). Tirzepatide, the active ingredient in the FDA-approved brands Mounjaro and Zepbound, activates both GIP and GLP-1 receptors to help regulate blood sugar, slow gastric emptying, and reduce appetite. It is used alongside diet and exercise in adults with type 2 diabetes and for chronic weight management. This compounded formulation is prescription-only and requires evaluation by a licensed healthcare provider.

What Does Tirzepatide/Pyridoxine(B6) 10/1 mg/mL Treat?

Type 2 diabetes mellitus (glycemic control in adults, with diet and exercise)
Chronic weight management in adults with obesity (BMI ?30)
Chronic weight management in adults who are overweight (BMI ?27) with a weight-related condition
Reduction of cardiometabolic risk factors as part of a supervised treatment plan
Moderate-to-severe obstructive sleep apnea in adults with obesity (tirzepatide, per Zepbound labeling)

Tirzepatide/Pyridoxine(B6) 10/1 mg/mL Dosage

Start: 2.5 mg subcutaneously once weekly for 4 weeks.
Then increase to 5 mg once weekly; may increase in 2.5 mg increments after at least 4 weeks at current dose.
Maximum: 15 mg subcutaneously once weekly.

Your prescriber will determine the dose and duration that are right for you. Always follow the directions on your prescription label.

Tirzepatide/Pyridoxine(B6) 10/1 mg/mL Side Effects

Common side effects

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion (dyspepsia)
  • Abdominal pain
  • Injection site reactions

Serious side effects

Stop taking this medication and seek medical attention right away if you experience:

  • Severe or persistent abdominal pain (possible pancreatitis)
  • Signs of thyroid tumor (neck lump, hoarseness, trouble swallowing)
  • Gallbladder problems (upper abdominal pain, fever, jaundice)
  • Severe hypoglycemia, especially with insulin or sulfonylureas
  • Serious allergic reaction (swelling, difficulty breathing)
  • Worsening kidney function, often from dehydration

Warnings & Interactions

Boxed warning: risk of thyroid C-cell tumors; do not use with personal/family history of medullary thyroid carcinoma or MEN 2
Not for use in type 1 diabetes or diabetic ketoacidosis
Risk of pancreatitis; discontinue if suspected
Increased hypoglycemia risk with insulin or insulin secretagogues; dose adjustment may be needed
May reduce effectiveness of oral contraceptives around initiation and dose increases; use backup contraception
Not recommended during pregnancy; discuss family planning with your provider
Delays gastric emptying; may affect absorption of oral medications

Tell your prescriber about all medications, supplements, and health conditions before starting tirzepatide/pyridoxine(b6) 10/1 mg/ml.

Talk to U.S.-Based Support

Our licensed pharmacy team in Boca Raton, Florida — real people, no overseas call centers.

Frequently Asked Questions

What is tirzepatide/pyridoxine (B6) 10/1 mg/mL?

It is a compounded injection containing tirzepatide, a GIP/GLP-1 receptor agonist, plus pyridoxine (vitamin B6). Tirzepatide is the active ingredient in the FDA-approved medications Mounjaro and Zepbound, used for type 2 diabetes and chronic weight management.

Do I need a prescription for tirzepatide/pyridoxine (B6)?

Yes. This is a prescription-only medication. A licensed healthcare provider must evaluate whether it is appropriate for you before it can be dispensed.

How does tirzepatide work?

Tirzepatide activates both GIP and GLP-1 receptors, which helps regulate insulin release, slow stomach emptying, and reduce appetite. Combined with diet and exercise, it can support blood sugar control and weight management under medical supervision.

Is compounded tirzepatide the same as Mounjaro?

Compounded tirzepatide contains the same active ingredient as Mounjaro but is prepared by a compounding pharmacy and includes added vitamin B6. Compounded products are not FDA-approved; your provider and pharmacist can discuss whether this option is right for you.

Why is vitamin B6 added to this formulation?

Pyridoxine (vitamin B6) is sometimes included in compounded tirzepatide formulations because it is thought to help ease nausea, a common side effect. Discuss the formulation with your pharmacist or provider if you have questions.

How does ordering and shipping work?

After your prescription is verified and reviewed by a licensed provider, the medication is dispensed by a licensed U.S. pharmacy and shipped in temperature-controlled packaging. Follow the storage instructions on your label when it arrives.

What is the usual starting dose of tirzepatide?

Treatment typically begins at 2.5 mg injected under the skin once weekly for 4 weeks, then increases to 5 mg weekly. Your provider may adjust the dose over time, up to a maximum of 15 mg once weekly.